Summit Therapeutics SMMT Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's payments to acquire property, plant, and equipment?
- Summit Therapeutics (SMMT) reported payments to acquire property, plant, and equipment of $245K in Q1 2026.
- How has Summit Therapeutics's payments to acquire property, plant, and equipment changed year-over-year?
- Summit Therapeutics's payments to acquire property, plant, and equipment decreased by 41.9% year-over-year, from $422K to $245K.
- What is the long-term trend for Summit Therapeutics's payments to acquire property, plant, and equipment?
- Over 3 years (2021 to 2025), Summit Therapeutics's payments to acquire property, plant, and equipment has grown at a 28.5% compound annual growth rate (CAGR), from $310K to $657K.